Myelodysplastic Syndrome
Showing NaN - NaN of 18
Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +1 more
Oct 4, 2023
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)
Terminated
- Acute Myeloid Leukemia
- +2 more
- ATIR101
- +3 more
-
Duarte, California
- +41 more
Apr 28, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)
Active, not recruiting
- Anemia
- +3 more
- Epoetin Alfa
- +2 more
-
Birmingham, Alabama
- +512 more
Mar 1, 2022
Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Iron Overload
-
Birmingham, Alabama
- +47 more
Jul 21, 2021
Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727
Completed
- Myelodysplastic Syndrome
- MDS
- ASTX727 Dose Escalation
- +2 more
-
Phoenix, Arizona
- +16 more
Dec 1, 2020
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Los Angeles, California
- +7 more
Jun 25, 2019
Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)
Completed
- Myelodysplastic Syndrome
- MEDI4736 Evaluate MEDI4736 in MDS
- +2 more
-
Scottsdale, Arizona
- +20 more
May 9, 2019
Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))
Terminated
- Myelodysplastic Syndrome
- vadastuximab talirine
- +2 more
-
Gilbert, Arizona
- +33 more
Jan 23, 2019
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (BVD-523)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Los Angeles, California
- +4 more
Jan 9, 2019
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (Panobinostat, Fludarabine, Cytarabine)
Terminated
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Panobinostat
- +4 more
-
Los Angeles, California
- +6 more
Nov 9, 2018
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)
Completed
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
-
Los Angeles, California
- +7 more
Jun 4, 2015
Myelodysplastic Syndrome Trial in United States (Antithymocyte globulin (ATG), Prednisone)
Unknown status
- Myelodysplastic Syndrome
- Antithymocyte globulin (ATG)
- Prednisone
-
Los Angeles, California
- +3 more
Jun 1, 2009
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (CT53518)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Los Angeles, California
- +4 more
Mar 23, 2009